These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22717389)

  • 1. Opiate use, treatment, and harm reduction in Afghanistan: recent changes and future directions.
    Todd CS; Macdonald D; Khoshnood K; Mansoor GF; Eggerman M; Panter-Brick C
    Int J Drug Policy; 2012 Sep; 23(5):341-5. PubMed ID: 22717389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing harm reduction for heroin users in Afghanistan, the worldwide opium supplier.
    Maguet O; Majeed M
    Int J Drug Policy; 2010 Mar; 21(2):119-21. PubMed ID: 20171864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding injecting drug use in Afghanistan: A scoping review.
    Nafeh F; Fusigboye S; Sornpaisarn B
    Subst Abuse Treat Prev Policy; 2022 Sep; 17(1):65. PubMed ID: 36123586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Golden Crescent and HIV/AIDS in Central Asia: deadly interactions.
    Beyrer C
    Glob Public Health; 2011; 6(5):570-6. PubMed ID: 21590558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition to injection amongst opioid users in Iran: implications for harm reduction.
    Malekinejad M; Vazirian M
    Int J Drug Policy; 2012 Jul; 23(4):333-7. PubMed ID: 21996166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?
    Bonny-Noach H
    Isr J Health Policy Res; 2019 Oct; 8(1):75. PubMed ID: 31619286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scale-up of a comprehensive harm reduction programme for people injecting opioids: lessons from north-eastern India.
    Lalmuanpuii M; Biangtung L; Mishra RK; Reeve MJ; Tzudier S; Singh AL; Sinate R; Sgaier SK
    Bull World Health Organ; 2013 Apr; 91(4):306-12. PubMed ID: 23599555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of People Who Inject Drugs in Tehran, Iran.
    Amin-Esmaeili M; Rahimi-Movaghar A; Gholamrezaei M; Razaghi EM
    Acta Med Iran; 2016 Dec; 54(12):793-805. PubMed ID: 28120592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative assessment of injection drug use and harm reduction programmes in Kabul, Afghanistan: 2006-2007.
    Todd CS; Stibich MA; Stanekzai MR; Rasuli MZ; Bayan S; Wardak SR; Strathdee SA
    Int J Drug Policy; 2009 Mar; 20(2):111-20. PubMed ID: 18207381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opium trade, insurgency, and HIV/AIDS in Afghanistan: relationships and regional consequences.
    Griffin N; Khoshnood K
    Asia Pac J Public Health; 2010 Jul; 22(3 Suppl):159S-167S. PubMed ID: 20566549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A harm reduction paradox: comparing China's policies on needle and syringe exchange and methadone maintenance.
    Smith K; Bartlett N; Wang N
    Int J Drug Policy; 2012 Jul; 23(4):327-32. PubMed ID: 22377341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operating needle exchange programmes in the hills of Thailand.
    Gray J
    AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 'do-it-yourself' New Zealand injecting scene: implications for harm reduction.
    Harris M
    Int J Drug Policy; 2013 Jul; 24(4):281-3. PubMed ID: 22884541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaling up opioid dependence treatment in low- and middle-income settings.
    Wu Z; Clark N
    Bull World Health Organ; 2013 Feb; 91(2):82-82A. PubMed ID: 23554516
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug abuse in Afghanistan.
    Gobar AH
    Bull Narc; 1976; 28(2):1-11. PubMed ID: 1048930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution of a harm reduction track for opiate agonist treatment: longitudinal impact on treatment retention, substance use and service utilization.
    Hartzler B; Cotton AJ; Calsyn DA; Guerra R; Gignoux E
    Int J Drug Policy; 2010 Jan; 21(1):82-5. PubMed ID: 19278847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid treatment in Ukraine risks losing momentum.
    Bull World Health Organ; 2013 Feb; 91(2):87-8. PubMed ID: 23554519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breaking worse: the emergence of krokodil and excessive injuries among people who inject drugs in Eurasia.
    Grund JP; Latypov A; Harris M
    Int J Drug Policy; 2013 Jul; 24(4):265-74. PubMed ID: 23726898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.
    Stone KA
    Harm Reduct J; 2015 Oct; 12():32. PubMed ID: 26472335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.